Recording a spike to drive a stimulus
Spike-triggered stimulation records an action potential at site A and uses it, within milliseconds, to trigger a stimulus at site B. Repeated over hours and days, this strengthens the A-to-B pathway — an artificial Hebbian synapse built from an electrode and a rule. In the classic demonstration (Jackson, Mavoori and Fetz, 2006), a free-behaving monkey carried an autonomous recording-and-stimulation device that conditioned one motor-cortex site on another, producing lasting changes in the cortical output map.
Timing is the whole game: the STDP window
The effect depends critically on the delay \Delta t between the two events — the spike-timing-dependent plasticity window. Pre-before-post within roughly tens of milliseconds potentiates the connection; the reversed order depresses it. Get the sign of \Delta t wrong and you weaken exactly the pathway you meant to strengthen.
The STDP learning window. Pre-before-post (positive delta t) potentiates; post-before-pre depresses; the time constants tau are on the order of tens of milliseconds. This is why loop latency and jitter are clinical parameters, not engineering footnotes.
Paired associative stimulation in humans
Paired associative stimulation (PAS) is the non-invasive analogue. Pair a peripheral nerve shock with transcranial magnetic stimulation over motor cortex, at an interval chosen so the afferent volley and the cortical pulse coincide, and repeat. This induces LTP- or LTD-like changes in corticospinal excitability, read out as a lasting change in the motor-evoked potential — Hebbian pairing you can run through the intact skull.
The BCI twist is to trigger the pairing on the patient's own state — an oscillatory phase or a movement-intention signal — rather than a fixed external clock. That brain-state-triggered PAS is the bridge into Guide 3.
Paired VNS: recruiting the neuromodulators
Paired vagus nerve stimulation pairs a different kind of signal. A brief burst of vagus nerve stimulation, time-locked to a rehab movement, releases neuromodulators — noradrenaline and acetylcholine — that gate plasticity and tag the co-active circuit for strengthening. The VNS-REHAB randomized trial supported this approach, and in 2021 a paired-VNS system received FDA clearance for chronic ischemic-stroke upper-limb rehabilitation — one of the few positive pivotal trials in the whole field.